Ledger.Open graph →
SEC Form D · Amendment · filed June 4, 2018

Purigen Biosystems, Inc

Offering
$30.8M
Sold
$26.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PLEASANTON, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Mitchell W. Mutz · Pleasanton, CADirectorBill W. Colston · Pleasanton, CADirectorSteve W. Reichenbach · Pleasanton, CAExecJuan Santiago · Pleasanton, CAPromoterJoseph J. Victor · Pleasanton, CADirectorKlint Rose · Pleasanton, CAExec · PromoterAndrew Schwab · Pleasanton, CADirectorDarrell Fox · Paauilo, HIExec · PromoterThomas N. Trkla · Beverly, MADirectorCaspar N. Romer · London, United KingdomDirectorSap Sinha · Basking Ridge, NJPromoterJack Pocorobba · Basking Ridge, NJDirectorBeach Investment Management, LLC · West Conshohocken, PADirectorEric Tarczynski · Allentown, NJExecBarnett Saunders · Pleasanton, CAExec · DirectorSean M. Dempsey · CHICAGO, ILDirectorJonathan B. Lewis · CHICAGO, ILExec · PromoterMichael Harward · Basking Ridge, NJExecAndrew G. Kim · New York, NYDirectorTanya Muro · ALISO VIEJO, CADirectorJames Hendren · Little Rock, ARDirectorDiane Stewart · Dallas, TXPromoterBarnett Saunders · Pleasanton, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗